<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM GENZYME TRANSGENICS CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> JAN-03-1999 <PERIOD-END> JUN-28-1998 <CASH> 10,691 <SECURITIES> 0 <RECEIVABLES> 7,003 <ALLOWANCES> 437 <INVENTORY> 11 <CURRENT-ASSETS> 27,337 <PP&E> 37,187 <DEPRECIATION> 8,397 <TOTAL-ASSETS> 74,152 <CURRENT-LIABILITIES> 20,106 <BONDS> 8,764 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 183 <OTHER-SE> 44,233 <TOTAL-LIABILITY-AND-EQUITY> 74,152 <SALES> 28,164 <TOTAL-REVENUES> 28,164 <CGS> 27,747 <TOTAL-COSTS> 37,557 <OTHER-EXPENSES> (100) <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 646 <INCOME-PRETAX> (9,939) <INCOME-TAX> (10) <INCOME-CONTINUING> (9,929) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (11,085) <EPS-PRIMARY> (.63) <EPS-DILUTED> (.63)